These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 7494570)
1. Schizophrenia. Kane JM N Engl J Med; 1996 Jan; 334(1):34-41. PubMed ID: 7494570 [No Abstract] [Full Text] [Related]
2. The long-term treatment of schizophrenia in the community. Rollin HR Practitioner; 1982 Jul; 226(1369):1330-3. PubMed ID: 6125936 [No Abstract] [Full Text] [Related]
3. [A practical guide for the use of psychopharmacologic agents. II. Antipsychotic and antiparkinson agents]. Chouinard G Union Med Can; 1976 Sep; 105(9):1387-97. PubMed ID: 9720 [No Abstract] [Full Text] [Related]
4. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia. Dursun S J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780 [No Abstract] [Full Text] [Related]
5. Central atropine-like toxicity in combined psychotropic drug administration. el-Yousef MK; Davis JM; Janowsky DS; Fann WE J Tenn Med Assoc; 1972 Aug; 65(8):719. PubMed ID: 4152620 [No Abstract] [Full Text] [Related]
6. Longterm maintenance therapy with depot haloperidol in schizophrenia. Zbytovský J Homeost Health Dis; 1991; 33(5-6):287. PubMed ID: 18265499 [No Abstract] [Full Text] [Related]
8. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses. Salvesen C; Vaksdal K Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740 [No Abstract] [Full Text] [Related]
9. Psychopharmacological treatment of schizophrenia. Lehmann HE Schizophr Bull; 1975; (13):27-45. PubMed ID: 1851 [No Abstract] [Full Text] [Related]
10. Advantages and disadvantages of depot-neuroleptics as maintenance medication for chronic schizophrenics. Möller HJ; Kissling W Clin Neuropharmacol; 1986; 9 Suppl 4():259-62. PubMed ID: 2882841 [No Abstract] [Full Text] [Related]
11. Approaching long-term neuroleptic treatment of schizophrenia. Hansell N JAMA; 1979 Sep; 242(12):1293-4. PubMed ID: 39181 [TBL] [Abstract][Full Text] [Related]
12. Depot antipsychotics in practice. Their rôle in schizophrenia and related psychoses. Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():1-78. PubMed ID: 2881965 [No Abstract] [Full Text] [Related]
13. [Is depot formulation a long-term optimal treatment option?]. Musch A Med Monatsschr Pharm; 2005 Nov; 28(11):414-6. PubMed ID: 16309031 [No Abstract] [Full Text] [Related]
14. Suicidal risk in the treatment of outpatient schizophrenics with long-acting neuroleptics. Niturad A; Nicholschi-Oproiu L Agressologie; 1978; 19(C):145-8. PubMed ID: 35993 [No Abstract] [Full Text] [Related]
15. Rehabilitation of the chronic schizophrenic patient: psychopharmacological aspects. Kristjansen P; Fog R; Munkvad I Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):54-8. PubMed ID: 14333 [No Abstract] [Full Text] [Related]
16. Neuroleptics, antiparkinsonian medication, and schizophrenia. Am J Psychiatry; 1981 Oct; 138(10):1389-90. PubMed ID: 6117202 [No Abstract] [Full Text] [Related]
17. [Importance of pharmacotherapy in the rehabilitation of schizophrenic patients]. Wojdysławska I Psychiatr Pol; 1977; 11(6):683-8. PubMed ID: 25450 [No Abstract] [Full Text] [Related]
18. What are the nursing implications when using paliperidone prolonged release for people with schizophrenia. Jones A J Psychiatr Ment Health Nurs; 2008 Dec; 15(10):792-9. PubMed ID: 19012670 [TBL] [Abstract][Full Text] [Related]
19. [To increase compliance-knowledge. Only every second schizophrenia patient remains faithful to the therapy]. MMW Fortschr Med; 2003 May; 145 Suppl 2():108. PubMed ID: 14579500 [No Abstract] [Full Text] [Related]
20. Use of long-acting risperidone. Parker G Psychiatr Serv; 2005 Jan; 56(1):105-6; author reply 106-7. PubMed ID: 15637203 [No Abstract] [Full Text] [Related] [Next] [New Search]